Efficacy of Pembrolizumab and Olaparib Combination Observed in a Subset of Patients with HRD Metastatic Pancreatic Cancer By Ogkologos - April 7, 2026 207 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the POLAR study Source RELATED ARTICLESMORE FROM AUTHOR Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism EMA Recommends Extension of Indications for Ponatinib Associated with a New Pharmaceutical Form and a New Strength MOST POPULAR Snowboarder Kimmy Fasani Diagnosed with Breast Cancer Nine Months After Son’s... December 11, 2021 New Research Discovers How Scalp Cooling Helps Chemo Patients Keep Their... February 6, 2021 FDA Approves Lurbinectedin in Combination with Atezolizumab or Atezolizumab and Hyaluronidase-tqjs... October 16, 2025 Dog Finds Woman’s Lost Wedding Ring At The Beach August 18, 2021 Load more HOT NEWS Zanidatamab Demonstrates Meaningful Clinical Benefit with a Manageable Safety Profile in... Safety, Tolerability and Antitumour Activity of Lorlatinib in Patients with ALK-Driven... Simple Hysterectomy Noninferior to Radical Hysterectomy with Respect to Pelvic Recurrence... Banking on breakthroughs for children and young people
